QIAGEN welcomes WHO’s new global guidelines on latent TB screening
Germantown, Maryland, and Hilden, Germany, February 22th, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today endorsed new guidelines issued by the World Health Organization (WHO), which coordinates global efforts to control tuberculosis (TB), calling for harmonization of preventive screening and treatment of latent TB infection among vulnerable groups in countries with a... Read more